It has been suggested that obestatin also reverses and protects against the development or progression of NAFLD directly, by modulating ghrelin and adiponectin signaling, or indirectly, by reducing food intake. The gene discussed is GHRL; the disease is metabolic dysfunction-associated steatotic liver disease.